CGEN
CGEN
NASDAQ · Biotechnology

Compugen Ltd

$2.33
-0.05 (-2.10%)
As of Sep 28, 10:19 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +1,894.0% upside
Low Target $33.82
Average Target $46.46
High Target $60.35
Current Price $2.33
Current
$2.33
Target
$46.46
$33.82 $46.46 avg $60.35
Scenario Analysis
Bear Case
$33.82
1,351.5%
Low target
Base Case
$46.46
+1,894.0%
Avg target
Bull Case
$60.35
+2,490.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.24
-28.0% from high
52-Week Low
$1.37
+70.1% from low
Target vs 52W High
$46.46
+1,336.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%